Carbonic anhydrase activators as potential anti-alzheimer’s disease agents

Protein Misfolding in Neurodegenerative Diseases: Mechanisms and Therapeutic Strategies

Volumn , Issue , 2007, Pages 265-288

  Supuran, Claudiu T ^a   Scozzafava, Andrea ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85056062662     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (61)

1. Alper, S.L. (2002) Genetic diseases of acid-base transporters. Annual Review of Physiology, 64, 899-923.
2. Briganti, F., Mangani, S., Orioli, P., Scozzafava, A., Vernaglione, G. and Supuran, C.T. (1997) Carbonic anhydrase activators: X-ray crystallographic and spectroscopic investigations for the interaction of isozymes I and II with histamine. Biochemistry, 36, 10384-10392.
3. Briganti, F., Iaconi, V., Mangani, S., Orioli, P., Scozzafava, A., Vernaglione, G. and Supuran, C.T. (1998) A ternary complex of carbonic anhydrase: X-ray crystallographic structure of the adduct of human carbonic anhydrase II with the activator phenylalanine and the inhibitor azide. Inorganica Chimica Acta, 275-276, 295-300.
4. Briganti, F., Scozzafava, A. and Supuran, C.T. (1999) Novel carbonic anhydrase isozymes I, II and IV activators incorporating sulfonyl-histamino moieties. Bioorganic and Medicinal Chemistry Letters, 9, 2043-2048.
5. Christianson, D.W. and Fierke, C.A. (1996) Carbonic anhydrase: evolution of the zinc binding site by nature and by design. Accounts of Chemical Research, 29, 331-339.
6. Clare, B.W. and Supuran, C.T. (1994) Carbonic anhydrase activators. Part 3. Structure- activity correlations for a series of isozyme II activators. Journal of Pharmaceutical Sciences, 83, 768-773.
7. De Coursey, T.E. (2000) Hypothesis: do voltage-gated Hþ channels in alveolar epithelial cells contribute to CO2 elimination by the lung? American Journal of Physiology. Cell Physiology, 278, C1-C10.
8. Gao, J.M., Qiao, S. and Whitesides, G.M. (1995) Increasing binding constants of ligands to carbonic anhydrase by using “greasy tails.” Journal of Medicinal Chemistry, 38, 2292-2301.
9. Halmi, P., Parkkila, S. and Honkaniemi, J. (2006) Expression of carbonic anhydrases II, IV, VII, VIII and XII in rat brain after kainic acid induced status epilepticus. Neurochemistry International, 48, 24-30.
10. Hewett-Emmett, D. (2000) Evolution and distribution of the carbonic anhydrase gene families. In The Carbonic Anhydrases-New Horizons, Chegwidden, W.R., Edwards, Y. and Carter, N. (Eds.), Birkhäuser Verlag, Basel, pp. 29-76.
11. Hipkiss, A.R. and Chana, H. (1998) Carnosine protects against methyl-glyoxal-mediated modifications. Biochemical and Biophysical Research Communications, 248, 28-32.
12. Ilies, M.A., Banciu, M.D., Ilies, M., Chiraleu, F., Briganti, F., Scozzafava, A. and Supuran, C.T. (1997) Carbonic anhydrase activators. Part 17. Synthesis and activation study of a series of 1-(1,2,4-triazole-(1H)-3-yl)-2,4,6-trisubstituted-pyridinium salts against isozymes I, II and IV. European Journal of Medicinal Chemistry, 32, 911-918.
13. Ilies, M., Banciu, M.D., Ilies, M.A., Scozzafava, A., Caproiu, M.T. and Supuran, C.T. (2002) Carbonic anhydrase activators: design of high affinity isozymes I, II, and IV activators, incorporating tri-=tetrasubstituted-pyridinium-azole moieties. Journal of Medicinal Chemistry, 45, 504-510.
14. Ilies, M., Scozzafava, A. and Supuran, C.T. (2004) Carbonic anhydrase activators. In Carbonic Anhydrase-Its Inhibitors and Activators, Supuran, C.T., Scozzafava, A. and Conway, J. (Eds.) CRC Press, Boca Raton 2004, pp. 317-352.
15. Khalifah, R.G. (1971) The carbonic dioxide hydration activity of carbonic anhydrase. Journal of Biological Chemistry, 246, 2561-2573.
16. Leiner, M. (1940) Das Ferment Kohlensäureanhydrase in Tierkörper. Naturwiss, 28, 316-317.
17. Mann, T. and Keilin, D. (1940) Sulphanilamide as a specific inhibitor of carbonic anhydrase. Nature, 146, 164-165.
18. Meyer-Ruge, W., Iwangoff, P. and Reichlmeier, K. (1984) Neurochemical enzyme changes in Alzheimer’s disease and Pick’s disease. Archives of Gerontology and Geriatrics, 3, 161-165.
19. Nair, S.K. and Christianson, D.W. (1991) Unexpected pH-dependent conformation of His-64, the proton shuttle of carbonic anhydrase II. Journal of American Chemical Society, 113, 9455-9458.
20. Page, M.I. and Williams, A. (1989) Enzyme Mechanism, Royal Society of Chemistry, London, pp. 1-13.
21. Parkes, J.L. and Coleman, P. (1989) Enhancement of carbonic anhydrase activity by erythrocyte membrane. Archives of Biochemistry and Biophysics, 275, 459-468.
22. Puscas, I., Supuran, C.T. and Manole, G. (1990) Carbonic anhydrase inhibitors. Part 3. Relations between chemical structure of inhibitors and activators. Revue Roumaine de Chimie, 35, 683-689.
23. Puscas, I., Coltau, M., Puscas, I.C. and Supuran, C.T. (1994) Carbonic anhydrase activators. Part 9. Kinetic parameters for isozyme II activation by histamine prove a non-competitive type of interaction. Revue Roumaine de Chimie, 39, 114-119.
24. Puscas, I., Coltau, M., Supuran, C.T., Moisi, F., Lazoc, L. and Farcau, D. (1996) Carbonic anhydrase activators. Part 10. Kinetic studies of isozyme II activation with pentagastrin. Revue Roumaine de Chimie, 41, 159-163.
25. Quinn, P.J., Boldyrev, A.A. and Formazuyk, V.E. (1992) Carnosine: its properties, functions and potential therapeutic applications. Molecular Aspects of Medicine, 13, 379-444.
26. Reithmeier, R.A. (2001) A membrane metabolon linking carbonic anhydrase with chloride= bicarbonate anion exchangers. Blood Cells, Molecules and Diseases, 27, 85-89.
27. Roth, D.E., Venta, P.J., Tashian, R.E. and Sly, W.S. (1992) Molecular basis of human carbonic anhydrase II deficiency. Proceedings of the National Academy of Sciences of the United States of America, 89, 1804-1808.
28. Rousselle, A.-V. and Heymann, D. (2002) Osteoclastic acidification pathways during bone resorption. Bone, 30, 533-540.
29. Scozzafava, A. and Supuran, C.T. (2000a) Carbonic anhydrase activators. Part 21. Novel activators of isozymes I, II and IV incorporating carboxamido and ureido histamine moieties. European Journal of Medicinal Chemistry, 35, 31-39.
30. Scozzafava, A. and Supuran, C.T. (2000b) Carbonic anhydrase activators. Part 24. High affinity isozymes I, II and IV activators, derivatives of 4-(4-chlorophenylsulfonylureido- amino acyl)ethyl-1H-imidazole. European Journal of Pharmaceutical Sciences, 10, 29-41.
31. Scozzafava, A. and Supuran, C.T. (2002a) Carbonic anhydrase activators: human isozyme II is strongly activated by oligopeptides incorporating the carboxyterminal sequence of the bicarbonate anion exchanger AE1. Bioorganic Medicinal Chemistry Letters, 12, 1177-1180.
32. Scozzafava, A. and Supuran, C.T. (2002b) Carbonic anhydrase activators: high affinity isozymes I, II, and IV activators, incorporating a b-alanyl-histidine scaffold. Journal of Medicinal Chemistry, 45, 284-291
33. Scozzafava, A., Menabuoni, L., Mincione, F., Briganti, F., Mincione, G. and Supuran, C.T. (1999) Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective intraocular pressure lowering aromatic=heterocyclic sulfonamides containing cationic or anionic moieties. Is the tail more important than the ring? Journal of Medicinal Chemistry, 42, 2641-2650.
34. Scozzafava, A., Briganti, F., Ilies, M.A. and Supuran, C.T. (2000a) Carbonic anhydrase inhibitors. Synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus the cytosolic isozymes. Journal of Medicinal Chemistry, 43, 292-300.
35. Scozzafava, A., Iorga, B. and Supuran, C.T. (2000b) Carbonic anhydrase activators: synthesis of high affinity isozymes I, II and IV activators, derivatives of 4-(4-tosylureido-amino acyl)ethyl-1H-imidazole (histamine derivatives). Journal of Enzyme Inhibition, 15, 139-161.
36. Shelton, J.B. and Chegwidden, W.R. (1988) Activation of carbonic anhydrase III by phosphate. Biochemical Society Transactions, 16, 853-854.
37. Stams, T. and Christianson, D.W. (2000) X-ray crystallographic studies of mammalian carbonic anhydrase isozymes. In The Carbonic Anhydrases-New Horizons, Chegwidden, W.R., Edwards, Y. and Carter, N. (Eds.), Birkhäuser Verlag, Basel, pp. 159-174, and references cited therein.
38. Sun, M.-K. and Alkon, D.L. (2001) Pharmacological enhancement of synaptic efficacy, spatial learning and memory through carbonic anhydrase activation in rats. Journal of Pharmacology and Experimental Therapeutics, 297, 961-967.
39. Sun, M.-K. and Alkon, D.L. (2002) Carbonic anhydrase gating of attention: memory therapy and enhancement. Trends in Pharmacological Sciences, 23, 83-89.
40. Sun, M.K., Dahl, D. and Alkon, D.L. (2001) Heterosynaptic transformation of GABAergic gating in the hippocampus and effects of carbonic anhydrase inhibition. Journal of Pharmacology and Experimental Therapeutics, 296, 811-817.
41. Supuran, C.T. (1992) Carbonic anhydrase activators. Part 4. A general mechanism of action for activators of isozymes I, II and III. Revue Roumaine de Chimie, 37, 411-421.
42. Supuran, C.T. and Balaban, A.T. (1994) Carbonic anhydrase activators. Part 8. pKa-activation relationship in a series of amino acid derivatives activators of isozyme II. Revue Roumaine de Chimie, 39, 107-113.
43. Supuran, C.T. and Puscas, I. (1994) Carbonic anhydrase activators. In Carbonic Anhydrase and Modulation of Physiologic and Pathologic Processes in the Organism, Puscas, I. (Ed.), Helicon, Timisoara, pp. 113-145.
44. Supuran, C.T. and Scozzafava, A. (1999) Carbonic anhydrase activators. Part 23. Aminoacyl= dipeptidyl histamine derivatives bind with high affinity to isozymes I, II and IV and act as efficient activators. Bioorganic Medicinal Chemistry, 7, 2397-2406.
45. Supuran, C.T. and Scozzafava, A. (2000a) Activation of carbonic anhydrase isozymes. In The Carbonic Anhydrases-New Horizons, Chegwidden, W.R., Edwards, Y. and Carter, N. (Eds.), Birkhäuser Verlag, Basel, pp. 197-219.
46. Supuran, C.T. and Scozzafava, A. (2000b) Carbonic anhydrase inhibitors and their therapeutic potential. Expert Opinion on Therapeutic Patents, 10, 575-600.
47. Supuran, C.T. and Scozzafava, A. (2000c) Carbonic anhydrase activators. Synthesis oh high affinity isozymes I, II and IV activators, derivatives of 4-(arylsulfonylureido-amino acyl)ethyl-1H-imidazole. Journal of Enzyme Inhibition, 15, 471-486.
48. Supuran, C.T. and Scozzafava, A. (2001) Carbonic anhydrase inhibitors. Current Medicinal Chemistry-Immunologic, Endocrine and Metabolic Agents, 1, 61-97.
49. Supuran, C.T., Dinculescu, A., Manole, G., Savan, F., Puscas, I. and Balaban, A.T. (1991) Carbonic anhydrase activators. Part 2. Amino acids and some of their derivatives may act as potent enzyme activators. Revue Roumaine de Chimie, 36, 937-946.
50. Supuran, C.T., Balaban, A.T., Cabildo, P., Claramunt, R.M., Lavandera, J.L. and Elguero, J. (1993a) Carbonic anhydrase activators. Part 7. Isozyme II activation with bis-azolylmethanes,- ethanes and related azoles. Biological and Pharmaceutical Bulletin, 16, 1236-1239.
51. Supuran, C.T., Dinculescu, A. and Balaban, A.T. (1993b) Carbonic anhydrase activators. Part 5. CA II activation by 2,4,6-trisubstituted pyridinium cations with 1-(v-aminoalkyl)side chains. Revue Roumaine de Chimie, 38, 343-349.
52. Supuran, C.T., Barboiu, M., Luca, C., Pop, E., Brewster, M.E. and Dinculescu, A. (1996a) Carbonic anhydrase activators. Part 14. Synthesis of mono- and bis-pyridinium salt derivatives of 2-amino-5-(2-aminoethyl)- and 2-amino-5-(3-aminopropyl)-1,3,4-thiadiazole, and their interaction with isozyme II. European Journal of Medicinal Chemistry, 31, 597-606.
53. Supuran, C.T., Claramunt, R.M., Lavandera, J.L. and Elguero, J. (1996b) Carbonic anhydrase activators. Part 15. A kinetic study of the interaction of bovine isozyme II with pyrazoles, bis- and tris-azolylmethanes. Biological and Pharmaceutical Bulletin, 19, 1417-1422.
54. Supuran, C.T., Scozzafava, A., Ilies, M.A., Iorga, B., Cristea, T., Briganti, F., Chiraleu, F. and Banciu, M.D. (1998) Carbonic anhydrase inhibitors. Part 53. Synthesis of substitutedpyridinium derivatives of aromatic sulfonamides: The first non polymeric membraneimpermeable inhibitors with selectivity for isozyme IV. European Journal of Medicinal Chemistry, 33, 577-594.
55. Supuran, C.T., Scozzafava, A. and Casini, A. (2003) Carbonic anhydrase inhibitors. Medicinal Research Reviews, 23, 146-189.
56. Supuran, C.T., Scozzafava, A. and Conway, J. (Eds.). (2004) Carbonic Anhydrase-Its Inhibitors and Activators, CRC Press, Boca Raton, pp. 1-368.
57. Temperini, C., Scozzafava, A., Puccetti, L. and Supuran, C.T. (2005) Carbonic anhydrase activators: X-ray crystal structure of the adduct of human isozyme II with L-histidine as a platform for the design of stronger activators. Bioorganic and Medicinal Chemistry Letters, 15, 5136-5141.
58. Temperini, C., Scozzafava, A., Vullo, D. and Supuran, C.T. (2006a) Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with L- and D-histidine and crystallographic analysis of their adducts with isoform II: engineering protontransfer processes within the active site of an enzyme. Chemistry, 12, 7057-7066.
59. Temperini, C., Scozzafava, A., Vullo, D. and Supuran, C.T. (2006b) Carbonic nhydrase activators. Activation of isoforms I, II, IV, VA, VII, and XIV with L- and D-phenylalanine and crystallographic analysis of their adducts with isozyme II: stereospecific recognition within the active site of an enzyme and its consequences for the drug design. Journal of Medicinal Chemistry, 49, 3019-3027.
60. Temperini, C., Scozzafava, A. and Supuran, C.T. (2006c) Carbonic anhydrase activators. The first X-ray crystallographic study of an adduct of isoform I. Bioorganic and Medicinal Chemistry Letters, 16, 5152-5156.
61. Vince, J.W. and Reithmeier, R.A. (2000) Identification of the carbonic anhydrase II binding site in the Cl_=HCO3_ anion exchanger AE1. Biochemistry, 39, 5527-5533.